Vitamin D and metabolites measurement by tandem mass spectrometry

Reviews in Endocrine and Metabolic Disorders

Volumn 14, Issue 2, 2013, Pages 159-184

  Van Den Ouweland, Johannes M W ^a   Vogeser, Michael ^b   Bächer, Silvia ^b  

^a CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Liquid chromatography tandem mass spectrometry (LC MS MS); Vitamin D and metabolites

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; 5,3 EPI 25 HYDROXYVITAMIN D3; AMMONIA; CALCIFEDIOL; SECALCIFEROL; UNCLASSIFIED DRUG; VITAMIN D;

ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ARTICLE; ATMOSPHERIC PRESSURE ELECTROSPRAY IONIZATION MASS SPECTROMETRY; AUTOMATION; CEREBROSPINAL FLUID ANALYSIS; DERIVATIZATION; DRIED BLOOD SPOT TESTING; ELECTROSPRAY MASS SPECTROMETRY; EPIMERIZATION; HALF LIFE TIME; HUMAN; HYDROXYLATION; IMMUNOASSAY; INTERMETHOD COMPARISON; IONIZATION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; METABOLITE; NONHUMAN; PRECIPITATION; PURIFICATION; QUANTITATIVE ANALYSIS; RADIORECEPTOR ASSAY; SALIVA ANALYSIS; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; STANDARDIZATION; TANDEM MASS SPECTROMETRY; VITAMIN D INTOXICATION; VITAMIN METABOLISM; WATER LOSS;

ANIMALS; CHROMATOGRAPHY, LIQUID; HUMANS; TANDEM MASS SPECTROMETRY; VITAMIN D;

EID: 84879689697     PISSN: 13899155     EISSN: 15732606     Source Type: Journal    
DOI: 10.1007/s11154-013-9241-0     Document Type: Article

References (119)

1. Hintzpeter B, Mensink GB, Thierfelder W, Muller MJ, Scheidt-Nave C. Vitamin D status and health correlates among German adults. Eur J Clin Nutr. 2008;62(9):1079-89. doi: 10.1038/sj.ejcn.1602825.
2. Arabi A, El Rassi R, El-Hajj Fuleihan G. Hypovitaminosis D in developing countries[mdash]prevalence, risk factors and outcomes. Nat Rev Endocrinol. 2010;6(10):550-61. doi: 10.1038/nrendo.2010.146.
3. Sattar N, Welsh P, Panarelli M, Forouhi NG. Increasing requests for vitamin D measurement: costly, confusing, and without credibility. Lancet. 2012;379(9811):95-6.
4. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-81. doi: 10.1056/NEJMra070553.
5. Jones G. Metabolism and biomarkers of Vitamin D. Scand J Clin Lab Invest. 2012;72(S243):7-13. doi: 10.3109/00365513.2012.681892.
6. Zerwekh JE. Blood biomarkers of vitamin D status. Am J Clin Nutr. 2008;87(4):1087S-91S.
7. Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010;376(9736):180-8.
8. Binkley N, Krueger D, Cowgill CS, Plum L, Lake E, Hansen KE, et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab. 2004;89(7):3152-7. doi: 10.1210/jc.2003-031979.
9. Higashi T, Awada D, Shimada K. Simultaneous determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma by liquid chromatography-tandem mass spectrometry employing derivatization with a Cookson-type reagent. Biol Pharm Bull. 2001;24(7):738-43.
10. Vogeser M, Kyriatsoulis A, Huber E, Kobold U. Candidate reference method for the quantification of circulating 25-hydroxyvitamin D3 by liquid chromatography-tandem mass spectrometry. Clin Chem. 2004;50(8):1415-7. doi: 10.1373/clinchem.2004.031831.
11. Stepman HC, Vanderroost A, Van Uytfanghe K, Thienpont LM. Candidate reference measurement procedures for serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 by using isotope-dilution liquid chromatography-tandem mass spectrometry. Clin Chem. 2011;57(3):441-8. doi: 10.1373/clinchem.2010.152553.
12. Tai SS, Bedner M, Phinney KW. Development of a candidate reference measurement procedure for the determination of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in human serum using isotope-dilution liquid chromatography-tandem mass spectrometry. Anal Chem. 2010;82(5):1942-8. doi: 10.1021/ac9026862.
13. Thienpont LM, Stepman HCM, Vesper HW. Standardization of measurements of 25-Hydroxyvitamin D3 and D2. Scand J Clin Lab Invest. 2012;72(S243):41-9. doi: 10.3109/00365513.2012.681950.
14. Adamec J, Jannasch A, Huang J, Hohman E, Fleet JC, Peacock M, et al. Development and optimization of an LC-MS/MS-based method for simultaneous quantification of vitamin D2, vitamin D3, 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3. J Sep Sci. 2011;34(1):11-20. doi: 10.1002/jssc.201000410.
15. Cai S-S, Syage JA. Comparison of atmospheric pressure photoionization, atmospheric pressure chemical ionization, and electrospray ionization mass spectrometry for analysis of lipids. Anal Chem. 2006;78(4):1191-9. doi: 10.1021/ac0515834.
16. 3in fat tissue. Endocrine. 2008;33(1):90-4. doi: 10.1007/s12020-008-9051-4.
17. Mawer EB, Backhouse J, Holman CA, Lumb GA, Stanbury SW. The distribution and storage of vitamin D and its metabolites in human tissues. Clin Sci. 1972;43(3):413-31.
18. Vieth R. The pharmacology of vitamin D. In: Feldman D, Pike JW, Adams JS, editors. Vitamin D. 3rd ed., Vol. Volume I. Academic Press, London, UK; 2011. pp. 1041-1066.
19. Robinson PD, Högler W, Craig ME, Verge CF, Walker JL, Piper AC, et al. The re-emerging burden of rickets: a decade of experience from Sydney. Arch Dis Child. 2006;91(7):564-8. doi: 10.1136/adc.2004.069575.
20. Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med. 2012;367(1):40-9. doi: 10.1056/NEJMoa1109617.
21. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53-8. doi: 10.1210/jc.2010-2704.
22. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-30. doi: 10.1210/jc.2011-0385.
23. Haddad JG, Chyu KJ. Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol Metab. 1971;33(6):992-5. doi: 10.1210/jcem-33-6-992.
24. Hollis BW. Assessment and interpretation of circulating 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in the clinical environment. Rheum Dis Clin N Am. 2012;38(1):29-44. doi: 10.1016/j.rdc.2012.03.005.
25. van den Ouweland JM, Beijers AM, Demacker PN, van Daal H. Measurement of 25-OH-vitamin D in human serum using liquid chromatography tandem-mass spectrometry with comparison to radioimmunoassay and automated immunoassay. J Chromatogr B Anal Technol Biomed Life Sci. 2010;878(15-16):1163-8. doi: 10.1016/j.jchromb.2010.03.035.
26. Roth HJ, Schmidt-Gayk H, Weber H, Niederau C. Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. Ann Clin Biochem. 2008;45(2):153-9. doi: 10.1258/acb.2007.007091.
27. Farrell C-JL, Martin S, McWhinney B, Straub I, Williams P, Herrmann M. State-of-the-Art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clin Chem. 2012;58(3):531-42. doi: 10.1373/clinchem.2011.172155.
28. Eisman JA, Shepard RM, DeLuca HF. Determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma using high-pressure liquid chromatography. Anal Biochem. 1977;80(1):298-305. doi: 10.1016/0003-2697(77) 90648-0.
29. De Leenheer AP, Cruyl AA. Vitamin D3 in plasma: quantitation by mass fragmentography. Anal Biochem. 1978;91(1):293-303. doi: 10.1016/0003-2697(78) 90843-6.
30. Watson D, Setchell KDR, Ross R. Analysis of vitamin D and its metabolites using thermospray liquid chromatography/mass spectrometry. Biomed Chromatogr. 1991;5(4):153-60. doi: 10.1002/bmc.1130050404.
31. El-Khoury JM, Reineks EZ, Wang S. Progress of liquid chromatography-mass spectrometry in measurement of vitamin D metabolites and analogues. [Review]. Clin Biochem. 2011;44(1):66-76. doi: 10.1016/j.clinbiochem.2010.05.007.
32. Higashi T, Shimada K, Toyo'oka T. Advances in determination of vitamin D related compounds in biological samples using liquid chromatography-mass spectrometry: a review. [Review]. J Chromatogr B Anal Technol Biomed Life Sci. 2010;878(20):1654-61. doi: 10.1016/j.jchromb.2009.11.026.
33. Vogeser M. Quantification of circulating 25-hydroxyvitamin D by liquid chromatography-tandem mass spectrometry. [Review]. J Steroid Biochem Mol Biol. 2010;121(3-5):565-73. doi: 10.1016/j.jsbmb.2010.02.025.
34. Vogeser M, Seger C. Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory. [Review]. Clin Chem. 2010;56(8):1234-44. doi: 10.1373/clinchem.2009.138602.
35. Bogusz MJ, Al Enazi E, Tahtamoni M, Jawaad JA, Al Tufail M. Determination of serum vitamins 25-OH-D2 and 25-OH-D3 with liquid chromatography-tandem mass spectrometry using atmospheric pressure chemical ionization or electrospray source and core-shell or sub-2 mum particle columns: a comparative study. Clin Biochem. 2011;44(16):1329-37. doi: 10.1016/j.clinbiochem.2011.08.1134.
36. Herrmann M, Harwood T, Gaston-Parry O, Kouzios D, Wong T, Lih A, et al. A new quantitative LC tandem mass spectrometry assay for serum 25-hydroxy vitamin D. Steroids. 2010;75(13-14):1106-12. doi: 10.1016/j.steroids.2010.07.006.
37. Musteata ML, Musteata FM. Overview of extraction methods for analysis of vitamin D and its metabolites in biological samples. Bioanalysis. 2011;3(17):1987-2002. doi: 10.4155/bio.11.195.
38. Couchman L, Benton CM, Moniz CF. Variability in the analysis of 25-hydroxyvitamin D by liquid chromatography-tandem mass spectrometry: the devil is in the detail. Clin Chim Acta. 2012;413(15-16):1239-43. doi: 10.1016/j.cca.2012.04.003.
39. Elder PA, Lewis JG, King RI, Florkowski CM. An anomalous result from gel tubes for vitamin D. Clin Chim Acta. 2009;410(1-2):95. doi: 10.1016/j.cca.2009. 09.037.
40. Higashi T, Shibayama Y, Fuji M, Shimada K. Liquid chromatography-tandem mass spectrometric method for the determination of salivary 25-hydroxyvitamin D3: a noninvasive tool for the assessment of vitamin D status. Anal Bioanal Chem. 2008;391(1):229-38. doi: 10.1007/s00216-007-1780-3.
41. Higashi T, Suzuki M, Hanai J, Inagaki S, Min JZ, Shimada K, et al. A specific LC/ESI-MS/MS method for determination of 25-hydroxyvitamin D3 in neonatal dried blood spots containing a potential interfering metabolite, 3-epi-25-hydroxyvitamin D3. J Sep Sci. 2011;34(7):725-32. doi: 10.1002/jssc.201000911.
42. Shah I, James R, Barker J, Petroczi A, Naughton DP. Misleading measures in Vitamin D analysis: a novel LC-MS/MS assay to account for epimers and isobars. Nutr J. 2011;10:46. doi: 10.1186/1475-2891-10-46.
43. Saenger AK, Laha TJ, Bremner DE, Sadrzadeh SM. Quantification of serum 25-hydroxyvitamin D(2) and D(3) using HPLC-tandem mass spectrometry and examination of reference intervals for diagnosis of vitamin D deficiency. Am J Clin Pathol. 2006;125(6):914-20. doi: 10.1309/J32U-F7GT-QPWN-25AP.
44. Bunch DR, Miller AY, Wang S. Development and validation of a liquid chromatography-tandem mass spectrometry assay for serum 25-hydroxyvitamin D2/D3 using a turbulent flow online extraction technology. Clin Chem Lab Med. 2009;47(12):1565-72.
45. Thibeault D, Caron N, Djiana R, Kremer R, Blank D. Development and optimization of simplified LC-MS/MS quantification of 25-hydroxyvitamin D using protein precipitation combined with on-line solid phase extraction (SPE). J Chromatogr B. 2012;883-884:120-7. doi: 10.1016/j.jchromb.2011.12.021.
46. Kushnir MM, Ray JA, Rockwood AL, Roberts WL, La'ulu SL, Whittington JE, et al. Rapid analysis of 25-hydroxyvitamin D2 and D3 by liquid chromatography-tandem mass spectrometry and association of vitamin D and parathyroid hormone concentrations in healthy adults. Am J Clin Pathol. 2010;134(1):148-56. doi: 10.1309/ajcppia7dfbt4gks.
47. Yuan C, Kosewick J, He X, Kozak M, Wang S. Sensitive measurement of serum 1α,25-dihydroxyvitamin D by liquid chromatography/tandem mass spectrometry after removing interference with immunoaffinity extraction. Rapid Commun Mass Spectrom. 2011;25(9):1241-9. doi: 10.1002/rcm.4988.
48. Chen H, McCoy LF, Schleicher RL, Pfeiffer CM. Measurement of 25-hydroxyvitamin D3 (25OHD3) and 25-hydroxyvitamin D2 (25OHD2) in human serum using liquid chromatography-tandem mass spectrometry and its comparison to a radioimmunoassay method. Clin Chim Acta. 2008;391(1-2):6-12. doi: 10.1016/j.cca.2008.01.017.
49. Duan X, Weinstock-Guttman B, Wang H, Bang E, Li J, Ramanathan M, et al. Ultrasensitive quantification of serum vitamin D metabolites using selective solid-phase extraction coupled to microflow liquid chromatography and isotope-dilution mass spectrometry. Anal Chem. 2010;82(6):2488-97. doi: 10.1021/ac902869y.
50. Maunsell Z, Wright DJ, Rainbow SJ. Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem. 2005;51(9):1683-90. doi: 10.1373/clinchem.2005.052936.
51. Knox S, Harris J, Calton L, Wallace AM. A simple automated solid-phase extraction procedure for measurement of 25-hydroxyvitamin D3 and D2 by liquid chromatography-tandem mass spectrometry. Ann Clin Biochem. 2009;46(Pt 3):226-30. doi: 10.1258/acb.2009.008206.
52. Netzel BC, Cradic KW, Bro ET, Girtman AB, Cyr RC, Singh RJ, et al. Increasing liquid chromatography-tandem mass spectrometry throughput by mass tagging: a sample-multiplexed high-throughput assay for 25-hydroxyvitamin D2 and D3. Clin Chem. 2011;57(3):431-40. doi: 10.1373/clinchem.2010.157115.
53. Højskov CS, Heickendorff L, Møller HJ. High-throughput liquid-liquid extraction and LCMSMS assay for determination of circulating 25(OH) vitamin D3 and D2 in the routine clinical laboratory. Clin Chim Acta. 2010;411(1-2):114-6. doi: 10.1016/j.cca.2009.10.010.
54. Jones G, Prosser DE. The activating enzymes of vitamin D metabolism (25- and 1alpha-Hydroxylases). In: Feldman D, Pike JW, Adams JS, editors. Vitamin D, Vol. Volume I. Academic Press, London, UK; 2011. pp. 23-42.
55. Strathmann FG, Laha TJ, Hoofnagle AN. Quantification of 1alpha,25-dihydroxy vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry. Clin Chem. 2011;57(9):1279-85. doi: 10.1373/clinchem.2010.161174.
56. Brumbaugh PF, Haussler DH, Bursac KM, Haussler MR. Filter assay for 1alpha, 25-dihydroxyvitamin D3. Utilization of the hormone's target tissue chromatin receptor. Biochemistry. 1974;13(20):4091-7.
57. Hollis BW. 1,25-Dihydroxyvitamin D3-26,23-lactone interferes in determination of 1,25-dihydroxyvitamin D by RIA after immunoextraction. Clin Chem. 1995;41(9):1313-4.
58. Kissmeyer A-M, Sonne K. Sensitive analysis of 1α,25- dihydroxyvitamin D3 in biological fluids by liquid chromatography-tandem mass spectrometry. J Chromatogr A. 2001;935(1-2):93-103. doi: 10.1016/s0021-9673(01) 00985-2.
59. Casetta B, Jans I, Billen J, Vanderschueren D, Bouillon R. Development of a method for the quantification of 1alpha,25(OH)2-vitamin D3 in serum by liquid chromatography tandem mass spectrometry without derivatization. Eur J Mass Spectrom (Chichester, Eng). 2010;16(1):81-9. doi: 10.1255/ejms.1024.
60. Aronov PA, Hall LM, Dettmer K, Stephensen CB, Hammock BD. Metabolic profiling of major vitamin D metabolites using Diels-Alder derivatization and ultra-performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2008;391(5):1917-30. doi: 10.1007/s00216-008-2095-8.
61. Wang Z, Senn T, Kalhorn T, Zheng XE, Zheng S, Davis CL, et al. Simultaneous measurement of plasma vitamin D(3) metabolites, including 4beta,25-dihydroxyvitamin D(3), using liquid chromatography-tandem mass spectrometry. Anal Biochem. 2011;418(1):126-33. doi: 10.1016/j.ab.2011.06.043.
62. Ding S, Schoenmakers I, Jones K, Koulman A, Prentice A, Volmer DA. Quantitative determination of vitamin D metabolites in plasma using UHPLC-MS/MS. Anal Bioanal Chem. 2010;398(2):779-89. doi: 10.1007/s00216-010-3993-0.
63. Tsikas D. Quantitative analysis of biomarkers, drugs and toxins in biological samples by immunoaffinity chromatography coupled to mass spectrometry or tandem mass spectrometry: A focused review of recent applications. J Chromatogr B. 2010;878(2):133-48. doi: 10.1016/j.jchromb.2009.11.008.
64. Kamao M, Tatematsu S, Hatakeyama S, Sakaki T, Sawada N, Inouye K, et al. C-3 epimerization of vitamin D3 metabolites and further metabolism of C-3 epimers. J Biol Chem. 2004;279(16):15897-907. doi: 10.1074/jbc.M311473200.
65. Brown AJ, Ritter C, Slatopolsky E, Muralidharan KR, Okamura WH, Reddy GS. 1α,25-Dihydroxy-3-Epi-vitamin D3, a natural metabolite of 1α,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion. J Cell Biochem. 1999;73(1):106-13. doi:10.1002/(sici)1097- 4644(19990401)73:1<106::aid-jcb12>3.0.co;2-q.
66. Fleet JC, Bradley J, Reddy GS, Ray R, Wood RJ. 1 alpha,25-(OH)2-vitamin D3 analogs with minimal in vivo calcemic activity can stimulate significant transepithelial calcium transport and mRNA expression in vitro. Arch Biochem Biophys. 1996;329(2):228-34. doi: 10.1006/abbi.1996.0213.
67. Singh RJ, Taylor RL, Reddy GS, Grebe SK. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab. 2006;91(8):3055-61. doi: 10.1210/jc.2006-0710.
68. Stepman HC, Vanderroost A, Stockl D, Thienpont LM. Full-scan mass spectral evidence for 3-epi-25-hydroxyvitamin D in serum of infants and adults. Clin Chem Lab Med. 2011;49(2):253-6. doi: 10.1515/CCLM.2011.050.
69. van den Ouweland JMW, Beijers AM, van Daal H. Fast separation of 25-hydroxyvitamin D3 from 3-Epi-25-hydroxyvitamin D3 in human serum by liquid chromatography-tandem mass spectrometry: variable prevalence of 3-Epi-25-hydroxyvitamin D3 in infants, children, and adults. Clin Chem. 2011;57(11):1618-9. doi: 10.1373/clinchem.2011.170282.
70. Lensmeyer GL, Wiebe DA, Binkley N, Drezner MK. HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays. Clin Chem. 2006;52(6):1120-6. doi: 10.1373/clinchem.2005.064956.
71. Schleicher RL, Encisco SE, Chaudhary-Webb M, Paliakov E, McCoy LF, Pfeiffer CM. Isotope dilution ultra performance liquid chromatography-tandem mass spectrometry method for simultaneous measurement of 25-hydroxyvitamin D2, 25-hydroxyvitamin D3 and 3-epi-25-hydroxyvitamin D3 in human serum. Clin Chim Acta. 2011;412(17-18):1594-9. doi: 10.1016/j.cca.2011.05.010.
72. Keevil B. Does the presence of 3-epi-25OHD(3) affect the routine measurement of vitamin D using liquid chromatography tandem mass spectrometry? Clin Chem Lab Med. 2011. doi: 10.1515/CCLM.2011.755.
73. Lensmeyer G, Poquette M, Wiebe D, Binkley N. The C-3 epimer of 25-hydroxyvitamin D3 is present in adult serum. J Clin Endocrinol Metab. 2012;97(1):163-8. doi: 10.1210/jc.2011-0584.
74. Strathmann FG, Sadilkova K, Laha TJ, Lesourd SE, Bornhorst JA, Hoofnagle AN, et al. 3-epi-25 hydroxyvitamin D concentrations are not correlated with age in a cohort of infants and adults. Clin Chim Acta. 2012;413(1-2):203-6. doi: 10.1016/j.cca.2011.09.028.
75. Baecher S, Leinenbach A, Wright JA, Pongratz S, Kobold U, Thiele R. Simultaneous quantification of four vitamin D metabolites in human serum using high performance liquid chromatography tandem mass spectrometry for vitamin D profiling. Clin Biochem. 2012. doi: 10.1016/j.clinbiochem.2012.06.030.
76. Reddy GS, Tserng KY. Calcitroic acid, end product of renal metabolism of 1,25-dihydroxyvitamin D3 through the C-24 oxidation pathway. Biochemistry. 1989;28(4):1763-9. doi: 10.1021/bi00430a051.
77. St-Arnaud R, Arabian A, Travers R, Barletta F, Raval-Pandya M, Chapin K, et al. Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is Due to elevated 1,25-dihydroxyvitamin D and Not to the absence of 24,25-dihydroxyvitamin D. Endocrinology. 2000;141(7):2658-66. doi: 10.1210/en.141.7.2658.
78. Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, John U, et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med. 2011;365(5):410-21. doi: 10.1056/NEJMoa1103864.
79. Dauber A, Nguyen TT, Sochett E, Cole DE, Horst R, Abrams SA, et al. Genetic defect in CYP24A1, the vitamin D 24-hydroxylase gene, in a patient with severe infantile hypercalcemia. J Clin Endocrinol Metab. 2012;97(2):E268-74. doi: 10.1210/jc.2011-1972.
80. Arnaud CD. Biochemical markers of bone turnover for predicting BMD in early postmenopausal women. J Clin Endocrinol Metab. 1998;83(3):1044-a-1045. doi: 10.1210/jc.83.3.1044-a.
81. Nakamura T, Kurokawa T, Orimo H. Increase of bone volume in vitamin D-repleted rats by massive administration of 24R,25(OH)2D3. Calcif Tissue Int. 1988;43(4):235-43.
82. Nakamura T, Kurokawa T, Orimo H. Increased mechanical strength of the vitamin D-replete rat femur by the treatment with a large dose of 24R,25(OH)2D3. Bone. 1989;10(2):117-23.
83. Wagner D, Hanwell HE, Schnabl K, Yazdanpanah M, Kimball S, Fu L, et al. The ratio of serum 24,25-dihydroxyvitamin D(3) to 25-hydroxyvitamin D(3) is predictive of 25-hydroxyvitamin D(3) response to vitamin D(3) supplementation. J Steroid Biochem Mol Biol. 2011;126(3-5):72-7. doi: 10.1016/j.jsbmb.2011.05.003.
84. Horst RL, Littledike ET, Gray RW, Napoli JL. Impaired 24,25-dihydroxyvitamin D production in anephric human and pig. J Clin Invest. 1981;67(1):274-80. doi: 10.1172/JCI110023.
85. Edouard T, Husseini A, Glorieux FH, Rauch F. Serum 24,25-dihydroxyvitamin D concentrations in osteogenesis imperfecta: relationship to bone parameters. J Clin Endocrinol Metab. 2012;97(4):1243-9. doi: 10.1210/jc.2011-3015.
86. Tanaka Y, Frank H, DeLuca HF, Koizumi N, Ikekawa N. Importance of the stereochemical position of the 24-hydroxyl to biological activity of 24-hydroxyvitamin D3. Biochemistry. 1975;14(15):3293-6. doi: 10.1021/bi00686a001.
87. Tsugawa N, Suhara Y, Kamao M, Okano T. Determination of 25-hydroxyvitamin D in human plasma using high-performance liquid chromatography-tandem mass spectrometry. Anal Chem. 2005;77(9):3001-7. doi: 10.1021/ac048249c.
88. Higashi T, Awada D, Shimada K. Determination of 24,25-dihydroxyvitamin D(3) in human plasma using liquid chromatography-mass spectrometry after derivatization with a Cookson-type reagent. Biomed Chromatogr. 2001;15(2):133-40. doi: 10.1002/bmc.43.
89. Bouillon R, Okamura WH, Norman AW. Structure-function relationships in the vitamin D endocrine system. Endocr Rev. 1995;16(2):200-57. doi: 10.1210/edrv-16-2-200.
90. Brown AJ, Slatopolsky E. Vitamin D analogs: therapeutic applications and mechanisms for selectivity. Mol Asp Med. 2008;29(6):433-52. doi: 10.1016/j.mam.2008.04.001.
91. Sauter G, Berr F, Beuers U, Fischer S, Paumgartner G. Serum concentrations of 7alpha-hydroxy-4-cholesten-3-one reflect bile acid synthesis in humans. Hepatology. 1996;24(1):123-6. doi: 10.1053/jhep.1996.v24. pm0008707250.
92. Shiraishi A, Higashi S, Ohkawa H, Kubodera N, Hirasawa T, Ezawa I, et al. The advantage of alfacalcidol over vitamin D in the treatment of osteoporosis. Calcif Tissue Int. 1999;65(4):311-6.
93. Napoli JL, Pramanik BC, Partridge JJ, Uskokovic MR, Horst RL. 23S,25-dihydroxyvitamin D3 as a circulating metabolite of vitamin D3. Its role in 25-hydroxyvitamin D3-26,23-lactone biosynthesis. J Biol Chem. 1982;257(16):9634-9.
94. Wichmann JK, DeLuca HF, Schnoes HK, Horst RL, Shepard RM, Jorgensen NA. 25-Hydroxyvitamin D3 26,23-lactone: a new in vivo metabolite of vitamin D. Biochemistry. 1979;18(22):4775-80.
95. Chace DH, Kalas TA, Naylor EW. The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism. [Review]. Annu Rev Genomics Hum Genet. 2002;3:17-45. doi: 10.1146/annurev.genom.3.022502.103213.
96. Eyles D, Anderson C, Ko P, Jones A, Thomas A, Burne T, et al. A sensitive LC/MS/MS assay of 25OH vitamin D3 and 25OH vitamin D2 in dried blood spots. Clin Chim Acta. 2009;403(1-2):145-51. doi: 10.1016/j.cca.2009.02.005.
97. Newman MS, Brandon TR, Groves MN, Gregory WL, Kapur S, Zava DT. A liquid chromatography/tandem mass spectrometry method for determination of 25-hydroxy vitamin D2 and 25-hydroxy vitamin D3 in dried blood spots: a potential adjunct to diabetes and cardiometabolic risk screening. J Diabetes Sci Technol. 2009;3(1):156-62.
98. Hollis BW, Wagner CL. Vitamin D deficiency during pregnancy: an ongoing epidemic. [Comment Editorial]. Am J Clin Nutr. 2006;84(2):273.
99. Ekins R. Measurement of free hormones in blood. [Review]. Endocr Rev. 1990;11(1):5-46.
100. Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab. 1986;63(4):954-9.
101. van Hoof HJC, Swinkels LMJW, Ross HA, Sweep CGJ, Benraad TJ. Determination of Non-protein-bound plasma 1,25-dihydroxyvitamin D by symmetric (rate) dialysis. Anal Biochem. 1998;258(2):176-83. doi: 10.1006/abio.1998.2586.
102. Gröschl M. Current status of salivary hormone analysis. Clin Chem. 2008;54(11):1759-69. doi: 10.1373/clinchem.2008.108910.
103. Fairney A, Saphier PW. Studies on the measurement of 25-hydroxy vitamin D in human saliva. Br J Nutr. 1987;57(1):13-25.
104. Holmoy T, Moen SM, Gundersen TA, Holick MF, Fainardi E, Castellazzi M, et al. 25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis. Mult Scler. 2009;15(11):1280-5. doi: 10.1177/ 1352458509107008.
105. Sempos CT, Vesper HW, Phinney KW, Thienpont LM, Coates PM. Vitamin D status as an international issue: national surveys and the problem of standardization. Scand J Clin Lab Invest Suppl. 2012;243:32-40. doi: 10.3109/00365513.2012.681935.
106. Phinney KW. Development of a standard reference material for vitamin D in serum. [Review]. Am J Clin Nutr. 2008;88(2):511S-2S.
107. Phinney K, Bedner M, Tai SS, Vamathevan V, Sander LC, Sharpless KE, et al. Development and certification of a standard reference material for vitamin D metabolites in human serum. Anal Chem. 2011. doi: 10.1021/ac202047n.
108. Certificate of analysis, Standard Reference Material 2972: 25-hydroxyvitamin D2 and D3 calibration solutions. Gaithersburg, MD: Standard Reference Materials Program, NIST (2009).
109. Carter GD. 25-Hydroxyvitamin D assays: the quest for accuracy. Clin Chem. 2009;55(7):1300-2. doi: 10.1373/clinchem.2009.125906.
110. Yates AM, Bowron A, Calton L, Heynes J, Field H, Rainbow S, et al. Interlaboratory variation in 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 is significantly improved if common calibration material is used. Clin Chem. 2008;54(12):2082-4. doi: 10.1373/clinchem.2008.110452.
111. Carter GD, Jones JC. Use of a common standard improves the performance of liquid chromatography-tandem mass spectrometry methods for serum 25-hydroxyvitamin-D. Ann Clin Biochem. 2009;46(1):79-81. doi: 10.1258/acb.2008.008135.
112. Carter GD. Accuracy of 25-hydroxyvitamin D assays: confronting the issues. [Review]. Curr Drug Targets. 2011;12(1):19-28.
113. Janssen MJW, Wielders JPM, Bekker CC, Boesten LSM, Buijs MM, Heijboer AC, et al. Multicenter comparison study of current methods to measure 25-hydroxyvitamin D in serum. Steroids. doi: 10.1016/j.steroids.2012.07.013.
114. Heijboer AC, Blankenstein MA, Kema IP, Buijs MM. Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration. Clin Chem. 2012;58(3):543-8. doi: 10.1373/clinchem.2011.176545.
115. Liel Y, Ulmer E, Shary J, Hollis BW, Bell NH. Low circulating vitamin D in obesity. Calcif Tissue Int. 1988;43(4):199-201.
116. 3in human plasma by liquid chromatography/electron capture atmospheric pressure chemical ionization-mass spectrometry. Anal Sci. 2003;19(6):941-3.
117. Gören AC, Bilsel G, Bilsel M. Rapid and simultaenous determination of 25-OH-vitamin D2 and D3 in human serum by LC/MS/MS: validation and uncertainty assessment. J Chem Metrl. 2007;1(1):1-9.
118. Priego Capote F, Jiménez JR, Granados JMM, de Castro MDL. Identification and determination of fat-soluble vitamins and metabolites in human serum by liquid chromatography/triple quadrupole mass spectrometry with multiple reaction monitoring. Rapid Commun Mass Spectrom. 2007;21(11):1745-54. doi: 10.1002/rcm.3014.
119. Xie W, Chavez-Eng CM, Fang W, Constanzer ML, Matuszewski BK, Mullett WM, et al. Quantitative liquid chromatographic and tandem mass spectrometric determination of vitamin D3 in human serum with derivatization: a comparison of in-tube LLE, 96-well plate LLE and in-tip SPME. J Chromatogr B Anal Technol Biomed Life Sci. 2011;879(17-18):1457-66. doi: 10.1016/j.jchromb.2011.03.018.